ZEROHour Newsletter: January 2019
|
|
You Made a Difference in 2018!
Patients and families have something to smile about as 2018 ends: record-setting generosity from donors supporting the community. Your donations exceeded the holiday matching funds goal, raising more than $300,000 for the fight to end prostate cancer!
Jamie Bearse, ZERO’s CEO, created this quick video to say thank you and preview the impactful programs these funds will support in 2019. You can also visit our website to learn how ZERO maximizes the impact your donations.
Building Community from Coast to Coast:
Introducing ZERO Live
New year and a new way for you to connect with ZERO! Introducing ZERO Live, an interactive way to bring you together with others who have been impacted by prostate cancer, as well as medical experts and ZERO staff.
Whether it’s interviewing patients and family members, or giving you the latest updates on the disease, ZERO Live is about bringing the community together and making us #ZEROStrong!
To join us, visit ZERO’s official Facebook page. Want a reminder about planned ZERO Live sessions? Visit the ZERO Facebook events section to get full details, let us know if you’re coming, and share with friends.
Facebook Live Q&A:
New Cancer Stats & Figures
Last week, the latest statistics were released for prostate cancer diagnoses and death rates in the U.S. The stats show mortality rate at its lowest point in history, but will this level off as men are discouraged from getting screened? Many in the prostate community have questions, and we’re here to help answer them.
Tune in to ZERO’s main Facebook page on January 15 at 4 p.m. for a live Q&A discussing the latest cancer figures. ZERO’s CEO, Jamie Bearse, will talk with Dr. Nilay Gandhi, a surgeon, urologist, and member of ZERO’s Medical Advisory Board. Visit ZERO’s Facebook Events page to mark your calendar and add your questions ahead of the event on Tuesday. Hope to see you then!
What is Chemotherapy? When is it Appropriate?
Some prostate cancer patients shy away from or choose not to utilize chemotherapy. Their hesitation may result from an outdated understanding of chemotherapy side effects and its effectiveness against prostate cancer.
Modern chemo is far from a last resort, and has been shown to significantly improve survival. On the ZERO Blog, Dr. William Oh dispels some of the myths and misunderstandings around chemo and its role when battling advanced prostate cancer.
Patient Navigation
|
|
ZERO360 Patient Support
Prostate cancer can be overwhelming. Whether you need help understanding your coverage options, finding sources of financial aid, or resolving issues with your insurance company, we are here to help. ZERO360 is your co-pilot in navigating your prostate cancer journey.
» Learn More About This Free Program
|
|
ZERO News
|
|
New Member of ZERO’s Board of Directors
ZERO welcomes Brad D. Lerner, M.D., F.A.C.S. as the newest member of its Board of Directors. Dr. Lerner offers 30+ years of experience in the urology field, as President of Chesapeake Urology Associates (CUA), Clinical Director of Summit Ambulatory Surgical Centers, and Urologic Consultant to the NFL Baltimore Ravens. Brad is a passionate advocate of prostate cancer research and is dedicated to helping men and their families fight this disease.
» More about ZERO’s newest board member
|
|
Help Men
|
|
ZERO Patient & Caregiver Surveys
Your feedback is essential to help us provide the most impactful programs to save lives from prostate cancer and stop pain and suffering. Please take 10 minutes or less to fill out our online surveys.
» Take a Quick Survey
|
|
Clinical Trials
|
|
Options for Advanced Disease
Clinical trials are a great way to pursue alternative treatment paths when standard treatments have failed. Are you being treated with androgen deprivation therapy for your prostate cancer? Talk to your health care provider about this clinical study for advanced prostate cancer patients sponsored by Bristol Myers Squibb:
» Clinical Trials Website
|
|
|
| 
| 
| 
